DNA gyrase, topoisomerase IV, and the 4-quinolones

Microbiology and Molecular Biology Reviews

Volumn 61, Issue 3, 1997, Pages 377-392

  Drlica, Karl ^a   Zhao, Xilin ^a  

^a PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 QUINOLONE DERIVATIVE; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING);

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; BACTERIOSTASIS; DNA REPAIR; DNA STRAND BREAKAGE; DNA SYNTHESIS INHIBITION; DRUG ACTIVITY; ENZYME INHIBITION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; NONHUMAN; REVIEW;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; POSIBACTERIA;

EID: 0031407768     PISSN: 10922172     EISSN: None     Source Type: Journal    
DOI: 10.1128/.61.3.377-392.1997     Document Type: Review

References (216)

1. Achari, A., and S. Neidle. 1976. Nalidixic acid. Acta Crystallogr. B32:600-602.
2. Adams, D., E. Shekhtman, E. Zechiedrich, M. Schmid, and N. Cozzarelli. 1992. The role of topoisomerase IV in partitioning bacterial replicons and the structure of catenated intermediates in DNA replication. Cell 71:277-288.
3. Alangaden, G. J., E. K. Manavathu, S. B. Vakulenko, N. M. Zvonok, and S. A. Lerner. 1995. Characterization of fluoroquinolone-resistant mutant strains of Mycobacterium tuberculosis selected in the laboratory and isolated from patients. Antimicrob. Agents Chemother. 39:1700-1703.
4. Bailone, A., S. Sommer, and R. Devoret. 1985. Mini-F plasmid-induced SOS signal in Escherichia coli is RecBC dependent. Proc. Natl. Acad. Sci. USA 82:5973-5977.
5. Bejar, S., and J. Bouche. 1984. The spacing of Escherichia coli DNA gyrase sites cleaved in vivo by treatment with oxolinic acid and sodium dodecyl sulfate. Biochimie 66:693-700.
6. Belland, R. J., S. G. Morrison, C. Ison, and W. M. Huang. 1994. Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates. Mol. Microbiol. 14:371-380.
7. Berger, J. M., S. J. Gamblin, S. C. Harrison, and J. C. Wang. 1996. Structure and mechanism of DNA topoisomerase II. Nature 379:225-232.
8. Bernard, P., and M. Couturier. 1991. The 41 carboxy-terminal residues of the miniF plasmid CcdA protein are sufficient to antagonize the killer activity of the CcdB protein. Mol. Gen. Genet. 226:297-304.
9. Bernard, P., and M. Couturier. 1992. Cell killing by the F plasmid CcdB protein involves poisoning of DNA-topoisomerase II complexes. J. Mol. Biol. 226:735-745.
10. Bernard, P., K. E. Kezdy, L. V. Melderen, J. Steyaert, L. Wyns, M. L. Pato, P. N. Higgins, and M. Couturier. 1993. The F plasmid CcdB protein induces efficient ATP-dependent DNA cleavage by gyrase. J. Mol. Biol. 234:534-541.
11. Blanche, R., B. Cameron, F.-X. Bernard, L. Maton, B. Manse, L. Ferrero, N. Ratet, C. Lecoq, A. Goniot, D. Bisch, and J. Crouzet. 1996. Differential behaviors of Staphylococcus aureus and Escherichia coli type II DNA topoisomerases. Antimicrob. Agents Chemother. 40:2714-2720.
12. Breines, D. M., S. Ouabdesselam, E. Y. Ng, J. Tankovic, S. Shah, C. J. Soussy, and D. C. Hooper. 1997. Quinolone resistance locus nfxD of Escherichia coli is a mutant allele of the parE gene encoding a subunit of topoisomerase IV. Antimicrob. Agents Chemother. 41:175-179.
13. Camacho-Carranza, R., J. Membrillo-Hernandez, J. Ramirez-Santos, J. Castro-Dorantes, V. C. Sanchez, and M. C. Gomez-Eichelmann. 1995. Topoisomerase activity during the heat shock response in Escherichia coli K-12. J. Bacteriol. 177:3619-3622.
14. Chaudhury, A. M., and G. R. Smith. 1985. Role of Escherichia coli RecBC enzyme in SOS induction. Mol. Gen. Genet. 201:525-528.
15. Chen, A. Y., and L. F. Liu. 1994. DNA topoisomerases: essential enzymes and lethal targets. Annu. Rev. Pharmacol. Toxicol. 34:191-218.
16. Chen, C.-R., and K. Drlica. Unpublished observations.
17. Chen, C.-R., M. Malik, M. Snyder, and K. Drlica. 1996. DNA gyrase and topoisomerase IV on the bacterial chromosome: quinolone-induced DNA cleavage. J. Mol. Biol. 258:627-637.
18. Chow, R., T. Dougherty, H. Fraimow, E. Bellin, and M. Miller. 1988. Association between early inhibition of DNA synthesis and the MICs and MBCs of carboxyquinolone antimicrobial agents for wild-type and mutant [gyrA nfxB(ompF) acrA] Escherichia coli K-12. Antimicrob. Agents Chemother. 32:1113-1118.
19. Coll, R., D. Gargallo-Viola, E. Tudela, M. A. Xicota, S. Llovera, and J. Guinea. 1996. Antibacterial activity and pharmacokinetics of four new 7-azetidinyl fluoroquinolones. Antimicrob. Agents Chemother. 40:274-277.
20. Craig, N. L., and J. W. Roberts. 1980. E. coli RecA protein-directed cleavage of phage lambda repressor requires polynucleotide. Nature 283:26-30.
21. Critchlow, S. E., and A. Maxwell. 1996. DNA cleavage is not required for the binding of quinolone drugs to the DNA gyrase-DNA complex. Biochemistry 35:7387-7393.
22. Crumplin, G. C., and J. T. Smith. 1975. Nalidixic acid: an antibacterial paradox. Antimicrob. Agents Chemother. 8:251-261.
23. Cullis, P. M., A. Maxwell, and D. P. Weiner. 1997. Exploiting nucleoside thiophosphates to probe mechanistic aspects of Escherichia coli gyrase. Biochemistry 36:6059-6068.
24. D'Arpa, P., C. Beardmore, and L. F. Liu. 1990. Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons. Cancer Res. 50:6919-6924.
25. DaVagnino, J., M. Herrero, D. Furlong, F. Morena, and R. Kolter. 1986. The DNA replication inhibitor microcin B17 is a forty-three-amino-acid protein containing sixty percent glycine. Proteins 1:230-238.
26. Deguchi, T., M. Yasuda, M. Nakano, S. Ozeki, T. Ezaki, I. Saito, and Y. Kawada. 1996. Quinolone-resistant Neisseria gonorrhoeae: correlation of alteration in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV with antimicrobial susceptibility profiles. Antimicrob. Agents Chemother. 40:1020-1023.
27. Deitz, W. H., T. M. Cook, and W. A. Goss. 1966. Mechanism of action of nalidixic acid on Escherichia coli. III. Conditions required for lethality. J. Bacteriol. 91:768-773.
28. DiNardo, S., K. Voelkel, R. Sternglanz, A. Reynolds, and A. Wright. 1982. Escherichia coli DNA topoisomerase I mutants have compensatory mutations in DNA gyrase genes. Cell 31:43-51.
29. Dorman, C., G. Barr, N. NiBhriain, and C. Higgins. 1988. DNA supercoiling and the anaerobic growth phase regulation of tonB gene expression. J. Bacteriol. 170:2816-2826.
30. Dorman, C., A. Lynch, N. NiBhriain, and C. Higgins. 1989. DNA supercoiling in Escherichia coli: topA mutations can be suppressed by DNA amplifications involving the tolC locus. Mol. Microbiol. 3:531-540.
31. 30a. Drlica, K. Unpublished observations.
32. Drlica, K., S. H. Manes, and E. C. Engle. 1980. DNA gyrase on the bacterial chromosome: possibility of two levels of action. Proc. Natl. Acad. Sci. USA 77:6879-6883.
33. Drlica, K., G. Pruss, R. Burger, R. Franco, L.-S. Hsieh, and B. Berger. 1990. Roles of DNA topoisomerases in bacterial chromosome structure and function, p. 195-204. In K. Drlica and M. Riley (ed.), The bacterial chromosome. American Society for Microbiology, Washington, D.C.
34. Drlica, K., and M. Snyder. 1978. Superhelical Escherichia coli DNA: relaxation by coumermycin. J. Mol. Biol. 120:145-154.
35. Drlica, K., C. Xu, J.-Y. Wang, R. M. Burger, and M. Malik. 1996. Fluoroquinolone action in mycobacteria: similarity to effects in Escherichia coli and detection by cell lysate viscosity. Antimicrob. Agents Chemother. 40: 1594-1599.
36. Engle, E. C., S. H. Manes, and K. Drlica. 1982. Differential effects of antibiotics inhibiting gyrase. J. Bacteriol. 149:92-98.
37. Esposito, F., and R. R. Sinden. 1987. Supercoiling in prokaryotic and eukaryotic DNA: changes in response to topological perturbation of plasmids in E. coli and SV40 in vitro, in nuclei, and in CV-1 cells. Nucleic Acids Res. 15:5105-5123.
38. 2+ complex on DNA: a new paradigm for the structure of a drug-DNA complex and implications for the structure of the quinolone bacterial gyrase-DNA complex. J. Med. Chem. 38:408-424.
39. Ferrero, L., B. Cameron, and J. Crouzet. 1995. Analysis of gyrA and grlA mutations in stepwise-selected ciprofloxacin-resistant mutants of Staphylococcus aureus. Antimicrob. Agents Chemother. 39:1554-1558.
40. Ferrero, L., B. Cameron, B. Manse, D. Lagneaux, J. Crouzet, A. Famechon, and F. Blanche. 1994. Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones. Mol. Microbiol. 13:641-653.
41. Filutowicz, M., and P. Jonczyk. 1983. The gyrB gene product functions in both initiation and chain polymerization on Escherichia coli chromosome replication: suppression of the initiation deficiency in gyrB-ts mutants by a class of rpoB mutations. Mol. Gen. Genet. 191:282-287.
42. Fisher, L. M., K. Mizuuchi, M. H. O'Dea, H. Ohmori, and M. Gellert. 1981. Site-specific interaction of DNA gyrase with DNA. Proc. Natl. Acad. Sci. USA 78:4165-4169.
43. Forsyth, M. H., A. S. Sayed, and S. J. Geary. 1995. Sequence and transcriptional analysis of the genes encoding the class-II topoisomerase of Mycoplasma gallisepticum. Gene 163:161-162.
44. Friedman, S. M., M. Malik, and K. Drlica. 1995. DNA supercoiling in a thermotolerant mutant of Escherichia coli. Mol. Gen. Genet. 248:417-422.
45. Gari, E., N. Figueroa, A.-B. Blanc-Potard, F. Spirito, M. B. Schmid, and L. Bossi. 1996. A class of gyrase mutants of Salmonella typhimurium show quinolone-like lethality and require Rec functions for viability. Mol. Microbiol. 21:111-122.
46. Garrido, M. C., M. Herrero, R. Kolter, and F. Moreno. 1988. The export of the DNA replication inhibitor microcin B17 provides immunity for the host cell. EMBO J. 7:1853-1862.
47. Gellert, M., R. Menzel, K. Mizuuchi, M. H. O'Dea, and D. Friedman. 1983. Regulation of DNA supercoiling in E. coli. Cold Spring Harbor Symp. Quant. Biol. 47:763-767.
48. Gellert, M., K. Mizuuchi, M. H. O'Dea, T. Itoh, and J.-L. Tomizawa. 1977. Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity. Proc. Natl. Acad. Sci. USA 74:4772-4776.
49. Gellert, M., M. H. O'Dea, K. Mizuuchi, and H. Nash. 1976. DNA gyrase: an enzyme that introduces superhelical turns into DNA. Proc. Natl. Acad. Sci. USA 73:3872-3876.
50. Georgiou, M., R. Munoz, F. Roman, R. Canton, R. Gomez-Lus, J. Campos, and A. G. D. L. Campa. 1996. Ciprofloxacin-resistant Haemophilus influenzae strains possess mutations in analogous positions of gyrA and parC. Antimicrob. Agents Chemother. 40:1741-1744.
51. Goldmark, P. J., and S. Linn. 1970. An endonuclease activity from Escherichia coli absent from certain rec-strains. Proc. Natl. Acad. Sci. USA 67:434-441.
52. Goldstein, E., and K. Drlica. 1984. Regulation of bacterial DNA supercoiling: plasmid linking number varies with growth temperature. Proc. Natl. Acad. Sci. USA 81:4046-4050.
53. Goss, W., W. Deitz, and T. Cook. 1965. Mechanism of action of nalidixic acid on Escherichia coli. II. Inhibition of deoxyribonucleic acid synthesis. J. Bacteriol. 89:1068-1074.
54. Grau, R., D. Gardiol, G. Gilkin, and D. de Mendoza. 1994. DNA supercoiling and thermal regulation of unsaturated fatty acid synthesis in Bacillus subtilis. Mol. Microbiol. 11:933-941.
55. Green, M., J. Donch, and J. Greenburg. 1970. Effect of inhibitors of DNA synthesis on UV-sensitive derivatives of Escherichia coli strain K-12. Mutat. Res. 9:149-154.
56. Griggs, D. J., K. Gensberg, and L. Piddock. 1996. Mutations in gyrA gene of quinolone-resistant Salmonella serotypes isolated from humans and animals. Antimicrob. Agents Chemother. 40:1009-1013.
57. Gudas, L. J., and A. B. Pardee. 1976. DNA synthesis inhibition and the induction of protein X in Escherichia coli. J. Mol. Biol. 101:459-477.
58. Guillemin, I., E. Cambau, and V. Jarlier. 1995. Sequences of conserved region in the A subunit of DNA gyrase from nine species of the genus Mycobacterium: phylogenetic analysis and implications for intrinsic susceptibility to quinolones. Antimicrob. Agents Chemother. 39:2145-2149.
59. Hane, M. W., and T. H. Wood. 1969. Escherichia coli K-12 mutants resistant to naladixic acid: genetic mapping and dominance studies. J. Bacteriol. 99:238-241.
60. Hayakawa, I., S. Atarashi, S. Yokohama, M. Imamura, K. Sakano, and M. Furukawa. 1986. Synthesis and antibacterial activities of optically active ofloxacin. Antimicrob. Agents Chemother. 29:163-164.
61. Heisig, P. 1993. High-level fluoroquinolone resistance in a Salmonella typhimurium isolate due to alterations in both gyrA and gyrB genes. J. Antimicrob. Chemother. 32:367-377.
62. Heisig, P. 1996. Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli. Antimicrob. Agents Chemother. 40:879-885.
63. Heisig, P., and B. Wiedemann. 1991. Use of a broad-host-range gyrA plasmid for genetic characterization of fluoroquinolone-resistant gram-negative bacteria. Antimicrob. Agents Chemother. 35:2031-2036.
64. Herrero, M., and F. Moreno. 1986. Microcin B17 blocks DNA replication and induces the SOS system in E. coli. J. Gen. Microbiol. 132:393-402.
65. Hiasa, H., R. DiGate, and K. Marians. 1994. Decatenating activity of Escherichia coli DNA gyrase and topoisomerases I and III during oriC and pBR322 DNA replication in vitro. J. Biol. Chem. 269:2093-2099.
66. Hiasa, H., and K. Marians. 1994. Topoisomerase IV can support oriC DNA replication in vitro. J. Biol. Chem. 269:16371-16375.
67. Higgins, C. F., C. J. Dorman, D. A. Stirling, L. Waddell, I. R. Booth, G. May, and E. Bremer. 1988. A physiological role for DNA supercoiling in the osmotic regulation of gene expression in S. typhimurium and E. coli. Cell 52:569-584.
68. Hoshino, K., A. Kitamura, I. Morrissey, K. Sato, J.-I. Kato, and H. Ikeda. 1994 Comparison of inhibition of Escherichia coli topoisomerase IV by quinolones with DNA gyrase inhibition. Antimicrob. Agents Chemother. 38:2623-2627.
69. Howard, B. M., R. J. Pinney, and J. T. Smith. 1993. 4-Quinolone bactericidal mechanisms. Arzneimittelforschung/Drug Res. 43:1125-1129.
70. Howard B. M., R. J. Pinney, and J. T. Smith. 1993. Function of the SOS process in repair of DNA damage induced by modern 4-quinolones. J. Pharm. Pharmacol. 45:658-662.
71. Hsiang, Y. H., M. G. Lihou, and L. F. Liu. 1989. Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin. Cancer Res. 49:5077-5082.
72. Hsieh, L.-S., R. M. Burger, and K. Drlica. 1991. Bacterial DNA supercoiling and [ATP]/[ADP]: changes associated with a transition to anaerobic growth. J. Mol. Biol. 219:443-450.
73. Hsieh, L.-S., J. Rouviere-Yaniv, and K. Drlica. 1991. Bacterial DNA supercoiling and [ATP]/[ADP]: changes associated with salt shock. J. Bacteriol. 173:3914-3917.
74. Huber, C. P., D. S. S. Gowda, and K. R. Acharya. 1980. Refinement of the structure of nalidixic acid. Acta Crystallogr. B36:497-499.
75. - mutant of Escherichia coli also carries a gyrA am mutation. The complete sequence of gyrA. Mol. Microbiol. 1:259-273.
76. Irbe, R. M., and M. Oishi. 1980. Prophage induction in a permeabilized cell system: induction by deoxyribonucleases and the role of recBC-deoxyribonuclease. J. Bacteriol. 144:1061-1067.
77. Jensen, P., L. Loman, B. Petra, C. vanderWeijden, and H. Westerhoff. 1995. Energy buffering of DNA structure fails when Escherichia coli runs out of substrate. J. Bacteriol. 177:3420-3426.
78. Kampranis, S. C., and A. Maxwell. 1996. Conversion of DNA gyrase into a conventional type II topoisomerase. Proc. Natl. Acad. Sci. USA 93:14416-14421.
79. Karem, K., and J. Foster. 1993. The influence of DNA topology on the environmental regulation of a pH-regulated locus in Salmonella typhimurium. Mol. Microbiol. 10:75-86.
80. Karu, A. E., and E. D. Belk. 1982. Induction of Escherichia coli recA protein via recBC and alternative pathways: quantitation by enzyme-linked immunosorbent assay (ELISA). Mol. Gen. Genet. 185:275-282.
81. Kato, J.-I., Y. Nishimura, R. Imamura, H. Niki, S. Hiraga, and H. Suzuki. 1990. New topoisomerase essential for chromosome segregation in E. coli. Cell 63:393-404.
82. Kato, J.-I., H. Suzuki, and H. Ikeda. 1992. Purification and characterization of DNA topoisomerase IV in Escherichia coli. J. Biol. Chem. 267:25676-25684.
83. Kato, J.-I., Y. Nishimura, and M. Hirota. 1988. Gene organization in the region containing a new gene involved in chromosome partition in Escherichia coli. J. Bacteriol. 170:3967-3977.
84. Khodursky, A. B., E. L. Zechiedrich, and N. R. Cozzarelli. 1995. Topoisomerase IV is a target of quinolones in Escherichia coli. Proc. Natl. Acad. Sci. USA 92:11801-11805.
85. Kirkegaard, K., and J. C. Wang. 1981. Mapping the topography of DNA wrapped around gyrase by nucleolytic and chemical probing of complexes of unique DNA sequences. Cell 23:721-729.
86. Kitamura, A., K, Hoshino, Y. Kimura, I. Hayakawa, and K. Sato. 1995. Contribution of the C-8 substituent of DU-6859a, a new potent fluoroquinolone, to its activity against DNA gyrase mutants of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 39:1467-1471.
87. Klevan, L., and J. C. Wang. 1980. Deoxyribonucleic acid gyrase-deoxyribonucleic acid complex containing 140 base pairs of deoxyribonucleic acid and an α-2 β-2 protein core. Biochemistry 19:5229-5234.
88. Klopman, G., D. Fercu, J.-Y. Li, H. S. Rosenkranz, and M. R. Jacobs. 1946 Antimycobacterial quinolones: a comparative analysis of structure-activity and structure-cytotoxicity relationships. Res. Microbiol. 147:86-96.
89. Koppen, A., S. Krobitsch, B. Thoms, and W. Wackernagel. 1995. Interaction with the recombination hot spot Chi in in vivo converts the RecBCD enzyme of Escherichia coli into a Chi-independent recombinase by inactivation of the RecD subunit. Proc. Natl. Acad. Sci. USA 92:6249-6253.
90. Krasin, F., and F. Hutchinson. 1977. Repair of DNA double-strand breaks in Escherichia coli, which requires recA function and the presence of a duplicate genome. J. Mol. Biol. 116:81-98.
91. Kreuzer, K. N., and N. R. Cozzarelli. 1979. Escherichia coli mutants thermosensitive for deoxyribonucleic acid gyrase subunit A: effects on deoxyribonucleic acid replication, transcription, and bacteriophage growth. J. Bacteriol. 140:424-435.
92. Kuemmerle, N. B., and W. E. Masker. 1980. Effect of the uvrD mutation on excision repair. J. Bacteriol. 142:535-546.
93. Kushner, S. R. 1974. Differential thermolability of exonuclease and endonuclease activities of the RecBC nuclease isolated from thermosensitive recB and recC mutants. J. Bacteriol. 120:1219-1222.
94. Kuzminov, A. 1995. Collapse and repair of replication forks in Escherichia coli. Mol. Microbiol. 16:373-384.
95. Lampe, M., and K. Bott. 1985. Genetic and physical organization of the cloned gyrA and gyrB genes of Bacillus subtilis. J. Bacteriol. 162:78-84.
96. Lewin, C., B. Howard, N. Ratcliffe, and J. Smith. 1989. 4-Quinolones and the SOS response. J. Med. Microbiol. 29:139-144.
97. Lewin, C., B. Howard, and J. Smith. 1991. Protein- and RNA-synthesis independent bactericidal activity of ciprofloxacin that involves the A subunit of DNA gyrase. J. Med. Microbiol. 34:19-22.
98. Lewin, C., I. Morrissey, and J. Smith. 1991. The mode of action of quinolones: the paradox in activity of low and high concentrations and activity in the anaerobic environment. Eur. J. Clin. Microbiol. Infect. Dis. 10:240-248.
99. Lewin, C., and J. Smith. 1990. Conditions required for the bactericidal activity of 4-quinolones against Serratia marcescens. J. Med. Microbiol. 32:211-214.
100. Lewin, C., and J. Smith. 1990. DNA breakdown by the 4-quinolones and its significance. J. Med. Microbiol. 31:65-70.
101. Lewin, C. S., and S. G. B. Ames. 1989. The bactericidal activity of R-3355, an optically active isomer of ofloxacin. J. Med. Microbiol. 30:227-231.
102. Lewin, C. S., S. G. B. Ames, and J. T. Smith. 1989. Bactericidal activity of enoxacin and lomefloxacin against Escherichia coli KL16. Eur. J. Clin. Microbiol. Infect. Dis. 8:731-733.
103. Lewin, C. S., I. Morrissey, and J. T. Smith. 1991. The fluoroquinolones exert a reduced rate of kill against Enterococcus faecalis. J. Pharm. Pharmacol. 43:492-494.
104. Li, L. H., T. J. Fraser, E. J. Olin, and B. K. Bhuyan. 1972. Action of camptothecin on mammalian cells in culture. Cancer Res. 32:2643-2650.
105. Little, J. W. 1983. Variations in the in vivo stability of LexA repressor during the SOS regulatory cycle, p. 369-378. In E. C. Friedberg and B. A. Bridges (ed.), Cellular responses to DNA damage. Alan R. Liss, Inc., New York, N.Y.
106. Little, J. W. 1991. Mechanism of specific LexA cleavage: autodigestion and the role of RecA coprotease. Biochimie 73:411-422.
107. Liu, L., and J. Wang. 1975. In vitro DNA synthesis on primed covalently closed double-stranded templates. I. Studies with Escherichia coli DNA polymerase I, p. 38-63. In M. Goulian, P. Hanawalt, and C. F. Fox (ed.), DNA synthesis and its regulation. Benjamin Cummings, Menlo Park, Calif.
108. Lockshon, D., and D. R. Morris. 1985. Sites of reaction of Escherichia coli DNA gyrase on pBR322 in vivo as revealed by oxolinic acid-induced plasmid linearization. J. Mol. Biol. 181:63-74.
109. Luttinger, A., A. Springer, and M. Schmid. 1991. A cluster of genes that affects nucleoid segregation in Salmonella typhimurium. New Biol. 3:687-697.
110. Maki, S., S. Takiguchi, T. Horiuchi, K. Sekimizu, and T. Miki. 1996. Partner switching mechanisms in inactivation and rejuvenation of Escherichia coli DNA gyrase by F plasmid proteins LetD (CcdB) and LetA (CcdA). J. Mol. Biol. 256:473.
111. Maki, S., S. Takiguchi, T. Miki, and T. Horiuchi. 1992. Modulation of DNA supercoiling activity of Escherichia coli DNA gyrase by F plasmid proteins. J. Biol. Chem. 267:12244-12251.
112. Malik, M., A. Bensaid, J. Rouviere-Yaniv, and K. Drlica. 1996. Histone-like protein HU and bacterial DNA topology: suppression of an HU deficiency by gyrase mutations. J. Mol. Biol. 256:66-76.
113. Manes, S. H., G. J. Pruss, and K. Drlica. 1983. Inhibition of RNA synthesis by oxolinic acid is unrelated to average DNA supercoiling. J. Bacteriol. 155:420-423.
114. 112a. Maxwell, A. Personal communication.
115. McCoy, E., L. Petrullo, and H. Rosenkranz. 1980. Non-mutagenic genotoxicants: novobiocin and nalidixic acid, two inhibitors of DNA gyrase. Mutat. Res. 79:33-43.
116. McDaniel, L. S., L. H. Rogers, and W. E. Hill. 1978. Survival of recombination-deficient mutants of Escherichia coli during incubation with nalidixic acid. J. Bacteriol. 134:1195-1198.
117. McNairn, E., N. Ni Bhriain, and C. Dorman. 1995. Overexpression of the Shigella flexneri genes coding for DNA topoisomerase IV compensates for loss of DNA topoisomerase I: effect on virulence gene expression. Mol. Microbiol. 15:507-517.
118. McPartland, A., L. Green, and H. Echols. 1980. Control of recA gene RNA in E. coli: regulatory and signal genes. Cell 20:731-737.
119. Menzel, R., and M. Gellert. 1983. Regulation of the genes for E. coli DNA gyrase: homeostatic control of DNA supercoiling. Cell 34:105-113.
120. Miki, T., J. Park, K. Nagao, N. Murayama, and T. Horiuchi. 1992. Control of segregation of chromosomal DNA by sex factor F in Escherichia coli: mutants of DNA gyrase subunit A suppress letD (ccdB) product growth inhibition. J. Mol. Biol. 225:39-52.
121. Miki, T., K. Yoshioka, and T. Horiuchi. 1984. Control of cell division by sex factor F in Escherichia coli. I. The 42.84-43.6 F segment couples cell division of the host bacteria with replication of plasmid DNA. J. Mol. Biol. 174:605-625.
122. Mizushima, T., S. Natori, and K. Sekimizu. 1993. Relaxation of supercoiled DNA associated with induction of heat shock proteins in Escherichia coli. Mol. Gen. Genet. 238:1-5.
123. Mojica, F., F. Charbonnier, G. Juez, F. Rodriguez-Valera, and P. Forterre. 1994. Effects of salt and temperature on plasmid topology in the halophilic archaeon Haloferax volcanii. J. Bacteriol. 176:4968-4973.
124. Moreau, N. J., H. Robaux, L. Baron, and X. Tabary. 1990. Inhibitory effects of quinolones on pro- and eucaryotic DNA topoisomerases I and II. Antimicrob. Agents Chemother. 34:1955-1960.
125. Morrison, A., and N. R. Cozzarelli. 1981. Contacts between DNA gyrase and its Binding site on DNA: features of symmetry and asymmetry revealed by protection from nucleases. Proc. Natl. Acad. Sci. USA 78:1416-1420.
126. Morrison, A., N. P. Higgins, and N. R. Cozzarelli. 1980. Interaction between DNA gyrase and its cleavage site on DNA. J. Biol. Chem. 255:2211-2219.
127. Morrissey, I., and J. T. Smith. 1994. The importance of oxygen in the killing of bacteria by ofloxacin and ciprofloxacin. Microbios 79:43-53.
128. Muñoz, R., and A. G. de la Campa. 1996. ParC subunit of DNA topoisomerase IV of Streptococcus pneumoniae is a primary target of fluoroquinolones and cooperates with DNA gyrase A subunit in forming resistance phenotype. Antimicrob. Agents Chemother. 40:2252-2257.
129. Murayama, N., H. Shimizu, S. Takiguchi, Y. Baba, H. Amino, T. Horiuchi, K. Sekimizu, and T. Miki. 1996. Evidence for involvement of Eschenchia coli genes pmbA, csrA, and a previously unrecognized gene tldD, in the control of DNA gyrase by letD (ccdB) of sex factor F. J. Mol. Biol. 256: 483-502.
130. Muskavitch, K. M. T., and S. Linn. 1981. recBC-like enzymes: exonuclease V deoxyribonucleases. Enzymes 14:233-250.
131. Myers, R., A. Kuzminov, and F. W. Stahl. 1995. The recombination hot spot X activates RecBCD recombination by converting Escherichia coli to a recD mutant phenocopy. Proc. Natl. Acad. Sci. USA 92:6244-6248.
132. Myers, R. S., and F. W. Stahl. 1994. Chi and the RecBCD enzyme of Escherichia coli. Annu. Rev. Genet. 28:49-70.
133. Nakamura, S., M. Nakamura, T. Kojima, and H. Yoshida. 1989. gyrA and gyrB mutations in quinolone-resistant strains of Escherichia coli. Antimicrob. Agents Chemother. 33:254-255.
134. Ng, E. Y., M. Trucksis, and D. C. Hooper. 1996. Quinolone resistance mutations in topoisomerase IV: relationship to the flqA locus and genetic evidence that topoisomerase IV is the primary target and DNA gyrase is the secondary target of fluoroquinolones in Staphylococcus aureus. Antimicrob. Agents Chemother. 40:1881-1888.
135. Nitiss, J., and J. C. Wang. 1988. DNA topoisomerase-targeting antitumor drugs can be studied in yeast. Proc. Natl. Acad. Sci. USA 85:7501-7505.
136. Oishi, M., C. L. Smith, and B. Friefeld. 1979. Molecular events and molecules that lead to induction of prophage and SOS functions. Cold Spring Harbor Symp. Quant. Biol. 43:897-907.
137. Oppegaard, H., and H. Sørum. 1994. gyrA mutations in quinolone-resistant isolates of the fish pathogen Aeromonas salmonicida. Antimicrob. Agents Chemother. 38:2460-2464.
138. Oram, M., and M. Fisher. 1991. 4-Quinolone resistance mutations in the DNA gyrase of Escherichia coli clinical isolates identified by using the polymerase chain reaction. Antimicrob. Agents Chemother. 35:387-389.
139. Orphanides, G., and A. Maxwell. 1994. Evidence for a conformational change in the DNA gyrase-DNA complex from hydroxyl radical footprinting. Nucleic Acids Res. 22:1567-1575.
140. Orr, E., N. F. Fairweather, I. Holland, and R. Pritchard. 1979. Isolation and characterization of a strain carrying a conditional lethal mutation in the cou gene of Escherichia coli K-12. Mol. Gen. Genet. 177:103-112.
141. Ouabdesselam, S., D. Hooper, J. Tankovic, and C. J. Soussy. 1995. Detection of gyrA and gyrB mutations in quinolone-resistant clinical isolates of Escherichia coli by single-strand conformational polymorphism analysis and determination of levels of resistance conferred by two different single gyrA mutations. Antimicrob. Agents Chemother. 39:1667-1670.
142. Pan, X.-S., J. Ambler, S. Mehtar, and L. M. Fisher. 1996. Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae. Antimicrob. Agents Chcmother. 40:2321-2326.
143. Pan, X.-S., and L. M. Fisher. 1997. Targeting of DNA gyrase in Streptococcus pneumoniae by sparfloxacin: selective targeting of gyrase or topoisomerase IV by quinolones. Antimicrob. Agents Chemother. 41:471-474.
144. Pan, X.-S., and S. M. Fisher. 1996. Cloning and characterization of the parC and parE genes of Streptococcus pneumoniae encoding DNA topoisomerase IV: role in fluoroquinolone resistance. J. Bacteriol. 178:4060-4069.
145. Pato, M., M. Howe, and N. P. Higgins. 1990. A DNA gyrase binding site at the center of the bacteriophage Mu genome required for efficient replicative transposition. Proc. Natl. Acad. Sci. USA 87:8716-8720.
146. Pato, M. L. 1994. Central location of the Mu strong gyrase binding site is obligatory for optimal rates of replicative transposition. Proc. Natl. Acad. Sci. USA 91:7056-7060.
147. Pato, M. L., M. Karlock, C. Wall, and N. P. Higgins. 1995. Characterization of Mu prophage lacking the central strong gyrase binding site: localization of the block in replication. J. Bacteriol. 177:5937-5942.
148. Peng, H., and K. Marians. 1993. Decatenation activity of topoisomerase IV during oriC and pBR322 DNA replication in vitro. Proc. Natl. Acad. Sci. USA 90:8571-8575.
149. Peng, H., and K. Marians. 1993. Escherichia coli topoisomerase IV: purification, characterization, subunit structure, and subunit interactions. J. Biol. Chem. 268:24481-24490.
150. Peng, H., and K. J. Marians. 1995. The interaction of Escherichia coli topoisomerase IV with DNA. J. Biol. Chem. 270:25286-25290.
151. Phillips, I., E. Culebras, F. Moreno, and F. Baquero. 1987. Induction of the SOS response by new 4-quinolones. J. Antimicrob. Chemother. 20:631-638.
152. Piddock, L., and R. Wise. 1987. Induction of the SOS response in Escherichia coli by 4-quinolone antimicrobial agents. FEMS Microbiol. Lett. 41:289-294
153. Power, E., and I. Phillips. 1992. Induction of the SOS gene (umuC) by 4-quinolone antibacterial drugs. J. Med. Microbiol. 36:78-82.
154. Power, E., and I. Phillips. 1993. Correlation between umuC induction and Salmonella mutagenicity assay for quinolone antimicrobial agents. FEMS Microbiol. Lett. 112:251-254.
155. Pruss, G., R. Franco, S. Chevalier, S. Manes, and K. Drlica. 1986. Effects of DNA gyrase inhibitors in Escherichia coli topoisomerase I mutants. J. Bacteriol. 168:276-282.
156. Pruss, G. J., S. H. Manes, and K. Drlica. 1982. Escherichia coli DNA topoisomerase I mutants: increased supercoiling is corrected by mutations near gyrase genes. Cell 31:35-42.
157. Rahman, M., G. Mauff, J. Levy, M. Couturier, G. Pulverer, and N. Glasdorff. 1994 Detection of 4-quinolone resistance mutation in gyrA gene of Shigella dysenteriae type 1 by PCR. Antimicrob. Agents Chemother. 38: 2488-2491.
158. Raji, A., D. J. Zabel, S. Laufer, and R. E. Depew. 1985. Genetic analysis of mutations that compensate for loss of Escherichia coli DNA topoisomerase I. J. Bacteriol. 162:1173-1179.
159. Rau, D., M. Gellert, F. Thoma, and A. Maxwell. 1987. Structure of the DNA gyrase-DNA complex as revealed by transient electric dichroism. J. Mol. Biol. 193:555-569.
160. Reece, R., and A. Maxwell. 1991. DNA gyrase: structure and function. Crit. Rev. Biochem. Mol. Biol. 26:335-375.
161. Revel, V., E. Cambau, V. Jarlier, and W. Sougakoff. 1994. Characterization of mutations in Mycobacterium smegmatis involved in resistance to fluoroquinolones. Antimicrob. Agents Chemother. 38:1991-1996.
162. Revel-Viravau, V., Q. C. Truong, N. Moreau, V. Jarlier, and W. Sougakoff. 1996. Sequence analysis, purification, and study of inhibition by 4-quinolones of the DNA gyrase from Mycobacterium smegmatis. Antimicrob. Agents Chemother. 40:2054-2061.
163. Reyna, F., M. Huesca, and Y. Fuchs. 1995. Salmonella typhimurium gyrA mutations associated with fluoroquinolone resistance. Antimicrob. Agents Chemother. 39:1621-1623.
164. Richardson, S. M. H., C. F. Higgins, and D. M. J. Lilley. 1984. The genetic control of DNA supercoiling in Salmonella typhimurium. EMBO J. 3:1745-1752.
165. Roca, J. 1995. The mechanisms of DNA topoisomerases. Trends Biochem. Sci. 20:156-160.
166. Roca, J., and J. C. Wang. 1992. The capture of a DNA double helix by an ATP-dependent protein clamp: a key step in DNA transport by type II DNA topoisomerases. Cell 71:833-840.
167. Roca, J., and J. C. Wang. 1994. DNA transport by a lype II DNA topoisomerase - evidence in favor of a two-gate mechanism. Cell 77:609-616.
168. Rodriguez-Sainz, M., C. Hernandez-Chico, and F. Moreno. 1990. Molecular characterization of pmbA, an Escherichia coli chromosomal gene required for the production of the antibiotic peptide MccB17. Mol. Microbiol. 4:1921-1932.
169. Sanchez, J. P., R. D. Gogliotti, J. M. Domagala, S. J. Gracheck, M. D. Huband, J. A. Sesnie, M. A. Cohen, and M. A. Shapiro. 1995. The synthesis, structure-activity, and structure-side effect relationships of a series of 8-alkoxy- and 5-amino-8-alkoxyquinolone antibacterial agents. J. Med. Chem. 38:4478-4487.
170. SanMillan, J. L., C. Hernandez-Chico, P. Pereda, and F. Moreno. 1985. Cloning and mapping of the genetic determinants for microcin B17 production and immunity. J. Bacteriol. 163:275-281.
171. SanMillan, J. L., C. Hernandez-Chico, P. Pereda, and F. Moreno. 1987. Evidence that colicin X is microcin B17. J. Bacteriol. 169:2899-2901.
172. Schmid, M. 1990. A locus affecting nucleoid segregation in Salmonella typhimurium. J. Bacteriol. 172:5416-5424.
173. Shen, L., J. Baranowski, and A. Pernet. 1989. Mechanism of inhibition of DNA gyrase by quinolone antibacterials: specificity and cooperativity of drug binding to DNA. Biochemistry 28:3879-3885.
174. Shen, L., L. Mitscher, P. Sharma, T. O'Donnell, D. Chu, C. Cooper, T. Rosen, and A. Pernet. 1989. Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a cooperative drug-DNA binding model. Biochemistry 28:3886-3894.
175. Shen, L. L., M. G. Bures, D. Chu, and J. J. Plattner. 1990. Quinolone-DNA interaction: how a small drug molecule acquires high DNA binding affinity and specificity, p. 495-512. In B. Pullman and J. Jortner (ed.). Molecular basis of specificity in nucleic acid-drug interactions. Kluwer Academic Publishers, Dordrecht, The Netherlands.
176. Shen, L. L., W. Kohlbrenner, D. Weigl, and J. Baranowski. 1989. Mechanism of quinolone inhibition of DNA gyrase: appearance of unique norfloxacin binding sites in enzyme-DNA complexes. J. Biol. Chem. 264:2973-2978.
177. Shen, L. L., and A. G. Pernet. 1985. Mechanism of inhibition of DNA gyrase by analogues of nalidixic acid: the target of the drugs is DNA. Proc. Natl. Acad. Sci. USA 82:307-311.
178. Shimizu, H., H. Yamaguchi, and H. Ikeda. 1995. Molecular analysis of λ bio transducing phage produced by oxolinic acid-induced illegitimate recombination in vivo. Genetics 140:889-896.
179. Shishido, K., N. Komiyama, and S. Ikawa. 1987. Increased production of a
180. Slilaty, S. N., J. A. Rupley, and J. W. Little. 1986. Intramolecular cleavage of LexA and phage lambda repressors: dependence of kinetics on repressor concentration, pH, temperature, and solvent. Biochemistry 25:6866-6875.
181. Smith, G. R. 1988. Homologous recombination in prokaryotes. Microbiol. Rev. 52-128.
182. Smith, G. R. 1990. RecBCD enzyme, p. 78-98. In F. Eckstein and D. Lilley (ed.), Nucleic acids and molecular biology. Springer-Verlag KG, Heidelberg, Germany.
183. Snyder, M., and K. Drlica. 1979. DNA gyrase on the bacterial chromosome: DNA cleavage induced by oxolinic acid. J. Mol. Biol. 131:287-302.
184. Sommer, S., A. Bailone, and R. Devoret. 1985. SOS induction by thermosensitive replication mutants of miniF plasmid. Mol. Gen. Genet. 198:456-464.
185. Soussy, C., J. Wolfson, E. Ng, and D. Hooper. 1993. Limitations of plasmid complementation test for determination of quinolone resistance due to changes in gyrase A protein and identification of conditional quinolone resistance locus. Antimicrob. Agents Chemother. 37:2588-2592.
186. Stahl, F. W., I. Kobayashi, and M. M. Stahl. 1983. Chi is activated by a variety of routes, p. 773-783. In N. R. Cozzarelli (ed.), Mechanisms of DNA replication and recombination. Alan R. Liss, Inc., New York, N.Y.
187. Steck, T. R., and K. Drlica. 1984. Bacterial chromosome segregation: evidence for DNA gyrase involvement in decatenation. Cell 36:1081-1088.
188. Steck, T. R., G. J. Pruss, S. H. Manes, L. Burg, and K. Drlica. 1984. DNA supercoiling in gyrase mutants. J. Bacteriol. 158:397-403.
189. Stewart, P., and R. D'Ari. 1992. Genetic and morphological characterization of an Escherichia coli chromosome segregation mutant. J. Bacteriol. 174:4513-4516.
190. Sugino, A., N. Higgins, P. Brown, C. Peebles, and N. Cozzarell,. 1978. Energy coupling in DNA gyrase and the mechanism of action of novobiocin. Proc. Natl. Acad. Sci. USA 75:4838-4842.
191. Sugino, A., C. Peebles, K. Kruezer, and N. Cozzarelli. 1977. Mechanism of action of nalidixic acid: purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme. Proc. Natl. Acad. Sci. USA 74:4767-4771.
192. Takenouchi, T., C. Ishii, M. Sugawara, Y. Tokue, and S. Ohya. 1995. Incidence of various gyrA mutants in 451 Staphylococcus aureus strains isolated in Japan and their susceptibilities to 10 fluoroquinolones. Antimicrob. Agents Chemother. 39:1414-1418.
193. Takiff, H., L. Salazar, C. Guerrero, W. Huang, B. Kreiswirth, S. Cole, W. Jacobs, and A. Telenti. 1994. Cloning and nucleotide sequence of the Mycobacterium tuberculosis gyrA and gyrB genes, and characterization of quinolone resistance mutations. Antimicrob. Agents Chemother. 38:773-780.
194. Trucksis, M., J. Wolfson, and D. Hooper. 1991. A novel locus conferring fluoroquinolone resistance in Staphylocccus aureus. J. Bacteriol. 173:5854-5860.
195. Tsao, Y.-P., A. Russo, G. Nyamuswa, R. Silber, and L. F. Liu. 1993. Interaction between replication forks and topoisomerase I-DNA cleavable complexes: studies in a cell-free SV49 DNA replication system. Cancer Res. 53:5908-5914.
196. Urios, A., G. Herrera, V. Aleixandre, and M. Blanco. 1991. Influence of recA mutations on gyrA dependent quinolone resistance. Biochimie 73:519-521.
197. Vila, J., J. Ruiz, P. Goni, and M. T. J. D. Anta. 1996. Detection of mutation in parC in quinolone-resistant clinical isolates of Escherichia coli. Antimicrob. Agents Chemother. 40:491-493.
198. Vizan, J. L., C. Hernandez-Chico, I. Castillo, and F. Moreno. 1991. The peptide antibiotic microcin B17 induces double-strand cleavage of DNA mediated by E. coli DNA gyrase. EMBO J. 10:467-476.
199. Volff, J.-N., D. Vandewiele, and B. Decaris. 1994. Stimulation of genetic instability and associated large genomic rearrangements in Streptomyces ambofaciens by three fluoroquinolones. Antimicrob. Agents Chemother. 38:1984-1940.
200. vonWright, A., and B. Bridges. 1981. Effect of gyrB-mediated changes in chromosome structure on killing of Escherichia coli by ultraviolet light: experiments with strains differing in deoxyribonucleic acid repair capacity. J. Bacteriol. 146:18-23.
201. Walker, G. C. 1984. Mutagenesis and inducible responses to deoxyribonucleic acid damage in Escherichia coli. Microbiol. Rev. 48:60-43.
202. Westerhoff, H., M. O'Dea, A. Maxwell, and M. Gellert. 1988. DNA supercoiling by DNA gyrase. A static head analysis. Cell Biophys. 12:157-181.
203. Willetts, N. S., and A. J. Clark. 1969. Characteristics of some multiply recombination-deficient strains of Escherichia coli. J. Bacteriol. 100:231-239.
204. Willmott, C. J., S. E. Critchlow, I. C. Eperon, and A. Maxwell. 1994. The complex of DNA gyrase and quinolone drugs with DNA forms a barrier to transcription by RNA polymerase. J. Mol. Biol. 242:351-363.
205. Winshell, E., and H. Rosenkranz. 1970. Nalidixic acid and the metabolism of Escherichia coli. J. Bacteriol. 104:1168-1175.
206. Worcel, A., and E. Burgi. 1972. On the structure of the folded chromosome of Escherichia coli. J. Mol. Biol. 71:127-147.
207. Xu, C., B. N. Kreiswirth, S. Sreevatsan, J. M. Musser, and K. Drlica. 1996. Fluoroquinolone resistance associated with specific gyrase mutations in clinical isolates of multidrug resistant Mycobacterium tuberculosis. J. Infect. Dis. 174:1127-1130.
208. Yamagishi, J., T. Kojima, Y. Oyamada, K. Fujimoto, H. Hattori, S. Nakamura, and M. Inoue. 1496. Alterations in the DNA topoisomerase IV grlA gene responsible for quinolone resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 40:1157-1163.
209. Yamagishi, J., H. Yoshida, M. Yamayoshi, and S. Nakamura. 1986. Nalidixie acid-resistant mutations of the gyrB gene of Escherichia coli. Mol. Gen. Genet. 204:367-373.
210. Yang, S.-W., A. B. Burgin, B. N. Huizenga, C. A. Robertson, K. C. Yao, and H. A. Nash. 1996. A eukaryotic enzyme that can disjoin dead-end covalent complexes between DNA and type I topoisomerases. Proc. Natl. Acad. Sci. USA 93:11534-11534.
211. Yoshida, H., M. Bogaki, M. Nakamura, and S. Nakamura. 1990. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob. Agents Chemother. 34:1271-1272.
212. Yoshida, H., M. Bogaki, M. Nakamura, L. Yamanaka, and S. Nakamura, 1991. Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli. Antimicrob. Agents Chemother. 35:1647-1650.
213. Yoshida, H., T. Kojima, J. Yamagishi, and S. Nakamura. 1988. Quinolone-resistant mutations of the gyrA gene of Escherichia coli. Mol. Gen. Genet. 211:1-7.
214. Zabinski, R. A., K. J. Walker, A. J. Larsson, J. A. Moody, G. W. Kaatz, and J. C. Rotschafer. 1995. Effect of aerobic and anaerobic environments on antistaphylococcal activities of five fluoroquinolones. Antimicrob. Agents Chemother. 39:507-512.
215. Zechiedrich, E. L., and N. R. Cozzarelli. 1995. Roles of topoisomerase IV and DNA gyrase in DNA unlinking during replication in Escherichia coli. Genes Dev. 9:2859-2869.
216. Zechiedrich, E. L., and N. Osheroff. 1990. Eukaryotic topoisomerases recognize nucleic acid topology by preferentially interacting with DNA crossovers. EMBO J. 9:4555-4562.